Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement

被引：179

作者：

Kallinich, Tilmann

Haffner, Dieter

Niehues, Tim

Huss, Kristina

Lainka, Elke

Neudorf, Ulrich

Schaefer, Christof

Stojanov, Silvia

Timmann, Christian

Keitzer, Rolf

Ozdogan, Huri

Ozen, Seza

机构：

[1] Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany

[2] Univ Hosp Rostock, Dept Pediat, Rostock, Germany

[3] Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-4000 Dusseldorf, Germany

[4] Univ Duisburg Gesamthsch, Dept Pediat, D-4100 Duisburg, Germany

[5] Childrens Univ Hosp, Dept Infect Dis & Immunol, Munich, Germany

[6] Berliner Betrieb Zent Gesundheitl Aufugaben, Berlin, Germany

[7] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany

[8] Istanbul Univ, Cerrahpasa Med Sch, Cerrahpasa, Turkey

[9] Hacettepe Univ, Fac Med, Dept Pediat Nephrol & Rheumatol, Ankara, Turkey

来源：

PEDIATRICS | 2007年 / 119卷 / 02期

关键词：

familial Mediterranean fever; colchicine; evidence-based guidelines; treatment;

D O I：

10.1542/peds.2006-1434

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.

引用

页码：E474 / E483

页数：10

共 50 条

[31] Canakinumab treatment in four children with colchicine resistant familial mediterranean fever
Ozkan, Solmaz
Atas, Bulent
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (06) : 945 - 947
[32] Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature
Yildirim, Deniz Gezgin
Fidan, Hatice Kibriya
Gonen, Sevirn
Soylemezoglu, Oguz
TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (02) : 175 - 181
[33] Effect of an increased dose of colchicine on microalbuminuria in children with Familial Mediterranean Fever
Marzouk, Huda
Mostafa, Noha
Khalifa, Iman
Badawi, Nora
EGYPTIAN RHEUMATOLOGIST, 2020, 42 (02) : 141 - 145
[34] Depression and anxiety in children and adolescents with familial Mediterranean fever
Balahan Makay
Neslihan Emiroğlu
Erbil Ünsal
Clinical Rheumatology, 2010, 29 : 375 - 379
[35] The other physician behind the use of colchicine for the treatment of familial Mediterranean fever
Aral, O
Özdogan, H
Yazici, H
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (05) : S13 - S14
[36] Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine
Lidar, M
Kedem, R
Langevitz, P
Pras, M
Livneh, A
JOURNAL OF RHEUMATOLOGY, 2003, 30 (12) : 2620 - 2623
[37] Mean platelet volume and β-thromboglobulin levels in familial mediterranean fever: Effect of colchicine use?
Abanonu, Gul Babacan
Daskin, Alper
Akdogan, Mehmet Fatih
Uyar, Seyit
Demirtunc, Refik
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (07) : 661 - 664
[38] Treatment of Familial Mediterranean Fever: Colchicine and Beyond
Gul, Ahmet
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (05): : 281 - 284
[39] Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever
Kiraz, S
Ertenli, I
Arici, M
Calguneri, M
Haznedaroglu, I
Celik, I
Pay, S
Kirazli, S
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (06) : 721 - 724
[40] Colchicine enhances intestinal permeability in patients with familial Mediterranean fever
Fradkin, A
Yahav, J
DiverHaber, A
Zemer, D
Jonas, A
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) : 241 - 245

← 1 2 3 4 5 →